Author = Hossein Asgarian-Omran
Relative Expression of BATF and CD112 in PBMC of Patients with Chronic Lymphocytic Leukemia

Volume 24, Issue 6, June 2023, Pages 2171-2176

Ahmad Najafi; Matine Sabaghi; Hossein Asgarian-Omran; Reza Valadan; Ramin Shekarriz; Ehsan Zaboli; Ghasem Janbabai; Mohsen Tehrani


Combined Blockade Of PD-1 and TIGIT is not Sufficient to Improve the Function Of CD8+ T-Cells in Chronic Lymphocytic Leukemia

Volume 23, Issue 7, July 2022, Pages 2225-2231

Fatemeh Hatefi; Hossein Asgarian-Omran; Hadi Hossein-Nataj; Armin Akbar; Ramin Shekarriz; Ehsan Zaboli; Ghasem Janbabai; Mohsen Tehrani


Expression Analysis of Fyn and Bat3 Signal Transduction Molecules in Patients with Chronic Lymphocytic Leukemia

Volume 21, Issue 9, September 2020, Pages 2615-2621

Fereshteh Hosseini-Valiki; Saeid Taghiloo; Golvash Tavakolian; Omolbanin Amjadi; Mohsen Tehrani; Akbar Hedayatizadeh-Omran; Reza Alizadeh-Navaei; Ehsan Zaboli; Ramin Shekarriz; Hossein Asgarian-Omran


Upregulation of Galectin-9 and PD-L1 Immune Checkpoints Molecules in Patients with Chronic Lymphocytic Leukemia

Volume 18, Issue 8, August 2017, Pages 2269-2274

Saeid Taghiloo; Esmaeil Allahmoradi; Reza Ebadi; Mohsen Tehrani; Zahra Hosseini-Khah; Ghasem Janbabai; Ramin Shekarriz; Hossein Asgarian-Omran


Tim-3 Up-regulation in Patients with Gastric Cancer and Peptic Ulcer Disease

Volume 18, Issue 3, March 2017, Pages 765-770

Mahdieh Naghavi-Alhosseini; Mohsen Tehrani; Abolghasem Ajami; Alireza Rafiei; Tarang Taghvaei; Laleh Vahedi-Larijani; Hadi Hossein-Nataj; Hossein Asgarian-Omran